These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 9108190

  • 1. Urine bactericidal activity of pefloxacin versus norfloxacin in healthy female volunteers after a single 800-mg oral dose.
    Hofbauer H, Naber KG, Kinzig-Schippers M, Sörgel F, Rustige-Wiedemann C, Wiedemann B, Reiz A, Kresken M.
    Infection; 1997; 25(2):121-6. PubMed ID: 9108190
    [Abstract] [Full Text] [Related]

  • 2. Urinary bactericidal activity and pharmacokinetics of enoxacin versus norfloxacin and ciprofloxacin in healthy volunteers after a single oral dose.
    Well M, Naber KG, Kinzig-Schippers M, Sörgel F.
    Int J Antimicrob Agents; 1998 Apr; 10(1):31-8. PubMed ID: 9624541
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Antibacterial activity of pefloxacin in the urine during the 7 days following a single 800 mg oral dose].
    Guibert J, Kitzis MD, Brumpt I, Acar JF.
    Pathol Biol (Paris); 1989 May; 37(5):406-10. PubMed ID: 2506514
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Antibacterial activity of ofloxacin in urine for 4 days after a single oral dose of 400 mg].
    Guibert J, Kitzis MD, Acar JF.
    Pathol Biol (Paris); 1998 Oct; 46(8):656-60. PubMed ID: 9871938
    [Abstract] [Full Text] [Related]

  • 7. [Antibacterial activity of lomefloxacin in the urine during the 4 days following a single 400 mg oral dose].
    Guibert J, Kitzis MD, Acar JF, Masquelier AM, Bellanger B.
    Pathol Biol (Paris); 1989 May; 37(5):411-4. PubMed ID: 2506515
    [Abstract] [Full Text] [Related]

  • 8. [Antibacterial activity of ciprofloxacin in the urine during four days after a single 500 mg and 750 mg oral dose].
    Guibert J, Kitzis MD, Acar JF.
    Pathol Biol (Paris); 1994 Jun; 42(6):587-92. PubMed ID: 7854859
    [Abstract] [Full Text] [Related]

  • 9. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
    Piccolomini R, Cellini L, Allocati N, Di Girolamo A, Selan L, Scazzocchio F.
    Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
    [Abstract] [Full Text] [Related]

  • 10. [Antibacterial activity of urine after administration of ofloxacin for 5 days].
    Drugeon H, Veyries ML, Levacher M, Garnier M, Aymard G, Giroud JP, Rouveix B.
    Therapie; 2000 Oct; 55(6):691-7. PubMed ID: 11234464
    [Abstract] [Full Text] [Related]

  • 11. Urinary pharmacodynamics of low-dose ciprofloxacin and ofloxacin.
    Stein GE, Schooley S, McMillan J.
    Diagn Microbiol Infect Dis; 1998 Apr; 30(4):261-5. PubMed ID: 9582586
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparative in vitro activities of norfloxacin (MK-0366) and six commonly used antimicrobial agents against 199 urinary isolates showing various degrees of antibiotic resistance.
    Corigliano BE, Appleman MD, Heseltine PN, Leedom JM.
    Diagn Microbiol Infect Dis; 1984 Apr; 2(2):101-6. PubMed ID: 6232085
    [Abstract] [Full Text] [Related]

  • 14. Comparative in vitro activity of five quinoline derivatives and five other antimicrobial agents used in oral therapy.
    Hoogkamp-Korstanje JA.
    Eur J Clin Microbiol; 1984 Aug; 3(4):333-8. PubMed ID: 6237901
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vitro antibacterial activity of three new quinolone derivatives: rosoxacin, norfloxacin, pefloxacin.
    Husson MO, Izard D, Leclerc H.
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Dec; 258(2-3):283-6. PubMed ID: 6241772
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Susceptibility to norfloxacin of some bacterial strains causing urinary infections].
    Tuchiluş C, Poiată A, Bădicuţ I, Buiuc D.
    Rev Med Chir Soc Med Nat Iasi; 2005 Dec; 109(2):383-6. PubMed ID: 16607805
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.